Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...

Women with a type of low-risk cancer might not have to rush aggressive treatment, doctors say.

B reast cancer is not a single disease but multiple ones, each carrying varying degrees of risk for endangering women’s ...

A HER2-positive status reflects breast cancer cells with extra copies of the HER2 gene, or higher expression of HER2 proteins ...

DCIS, known as stage 0 breast cancer, affect the cells lining the milk ducts but has not spread outside the breast.

Interim overall survival (OS) analyses at 31% maturity in patients with ESR1 mutations, and 23% maturity among all patients, ...

The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according ...

Detections of ctDNA at baseline in patients with HR-positive early breast cancer were associated with larger tumor size.

Further research is needed to address racial disparities and optimize therapeutic approaches in breast cancer treatment.

Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent ...

Virginia G. Kaklamani, MD, DSc, discusses how effective elacestrant (Orserdu) is in CDK4/6 inhibitor-naive estrogen ...

Pfizer said Thursday its drug Ibrance showed efficacy in a group of breast cancer patients who do not currently have access ...